QuiVad

Home / Japan / Nxera Pharma Co.,Ltd.

Nxera Pharma Co.,Ltd.

Short position disclosed on November 2, 2026.

Follow

Evolution of the disclosed total

0%2%4%6%8%
Aug 22Sep 10Sep 29Oct 18
Sum of open short positions, as % of capital. Hover or tap the curve to see which funds make it up.

Open positions

The funds disclosing a short position that is still open.
FundTwelve months% of capitalOver the yearSince
Linden Capital L.P.2.25%newNovember 2, 2026
Goldman Sachs International0.87%newOctober 29, 2026

Follow by RSS

Get the moves on Nxera Pharma Co.,Ltd. by mail, at most once a day.

There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.

History of disclosures

108 disclosures on record for this share.
DateFund% of capitalEnd of publication
August 7, 2026UBS AG0.68%
August 6, 2026Goldman Sachs International1.56%
August 6, 2026Barclays Capital Securities Ltd1.11%
August 6, 2026UBS AG0.79%
August 5, 2026Goldman Sachs International1.60%
August 5, 2026Barclays Capital Securities Ltd1.09%
August 3, 2026Citigroup Global Markets Limited1.00%
August 3, 2026Barclays Capital Securities Ltd0.95%

Download 108 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats

Other companies sold short in Japan

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Nxera Pharma Co.,Ltd., source JPX, data as at November 2, 2026, https://www.quivad.com/action/nxera-pharma-co-ltd?page=3